Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Pond

Showing results (51-60 of 255) with videos related to

Pageof 26
Sort By:
Journal of Geriatric Oncology|May 31, 2020
Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatmentHira Mian, Gregory R Pond, Sascha A Tuchman, et al.
Radiation Oncology (London, England)|March 23, 2012
A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastasesGeorge Rodrigues, Slav Yartsev, Keng Yeow Tay, et al.
Oncology Research and Treatment|December 23, 2014
Prognostic impact of C-reactive protein in metastatic prostate cancer: a systematic review and meta-analysisPedro Rocha, Charity J Morgan, Arnoud J Templeton, et al.
Cancer Treatment and Research Communications|November 28, 2020
The impact of synchronous malignancies on survival in patients with early stage curable non-small-cell lung cancerAmit Singnurkar, Anand Swaminath, Ur Metser, et al.
Arthritis and Rheumatism|October 2, 2002
Predictors of infection in rheumatoid arthritisMichele F Doran, Cynthia S Crowson, Gregory R Pond, et al.
Anti-Cancer Drugs|December 11, 2012
Influence of statistician involvement on reporting of randomized clinical trials in medical oncologyJulien Péron, Benoit You, Hui K Gan, et al.
Arthritis and Rheumatism|October 2, 2002
Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based studyMichele F Doran, Cynthia S Crowson, Gregory R Pond, et al.
Cancer|July 14, 2007
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancerRachel P Riechelmann, Carol A Townsley, Sheray N Chin, et al.
Arthritis and Rheumatism|March 29, 2002
Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year periodMichele F Doran, Gregory R Pond, Cynthia S Crowson, et al.
Haematologica|December 23, 2020
Symptom burden in transplant ineligible patients with newly diagnosed multiple myeloma: a population-based cohort studyHira S Mian, Gregory R Pond, Tanya M Wildes, et al.
Pageof 26

Showing results (51-60 of 255) with videos related to

Sort By:
Pageof 26
Journal of Geriatric Oncology|May 31, 2020
Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatmentHira Mian, Gregory R Pond, Sascha A Tuchman, et al.
Radiation Oncology (London, England)|March 23, 2012
A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastasesGeorge Rodrigues, Slav Yartsev, Keng Yeow Tay, et al.
Oncology Research and Treatment|December 23, 2014
Prognostic impact of C-reactive protein in metastatic prostate cancer: a systematic review and meta-analysisPedro Rocha, Charity J Morgan, Arnoud J Templeton, et al.
Cancer Treatment and Research Communications|November 28, 2020
The impact of synchronous malignancies on survival in patients with early stage curable non-small-cell lung cancerAmit Singnurkar, Anand Swaminath, Ur Metser, et al.
Arthritis and Rheumatism|October 2, 2002
Predictors of infection in rheumatoid arthritisMichele F Doran, Cynthia S Crowson, Gregory R Pond, et al.
Anti-Cancer Drugs|December 11, 2012
Influence of statistician involvement on reporting of randomized clinical trials in medical oncologyJulien Péron, Benoit You, Hui K Gan, et al.
Arthritis and Rheumatism|October 2, 2002
Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based studyMichele F Doran, Cynthia S Crowson, Gregory R Pond, et al.
Cancer|July 14, 2007
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancerRachel P Riechelmann, Carol A Townsley, Sheray N Chin, et al.
Arthritis and Rheumatism|March 29, 2002
Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year periodMichele F Doran, Gregory R Pond, Cynthia S Crowson, et al.
Haematologica|December 23, 2020
Symptom burden in transplant ineligible patients with newly diagnosed multiple myeloma: a population-based cohort studyHira S Mian, Gregory R Pond, Tanya M Wildes, et al.
Pageof 26